Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP® and SAS®

Chapter 4: Detecting Fraud at the Clinical Site


Is your company moving toward risk-based monitoring of clinical trials as recommended by the FDA? Are you concerned about the integrity and quality of your clinical trials data? Can you tell the difference between bad data and fraud? Richard Zink’s new book Risk-Based Monitoring and Fraud Detection in Clinical Trials Using JMP® and SAS® presents a practical approach for centralized monitoring of clinical trials using JMP Clinical software.

In chapter 4, "Detecting Fraud at the Clinical Site," Zink presents specific examples and explores graphical and statistical approaches for identifying both site- and patient-perpetrated fraud.

Ultimately, says Zink, “A proactive, risk-based approach to quality in clinical trials will more effectively protect the individuals participating in clinical trials.”

*
*
*
*
  JMP 사용자를 위한 뉴스레터 수신에 동의합니다.
  JMP 관련 행사 정보 수신에 동의합니다. 언제든지 수신 거부할 수 있습니다.

JMP는 SAS Institute Inc.의 한 부서이며 귀하의 정보는 SAS 개인 정보 보호 정책 준칙에 따라 존중하며 보호합니다.

 
 

Back to Top